Tab. 2.
Ligand | 1AL9a | 1K9G | 1KCI | 1P20 | 1Z3F | |||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
1b | 2b | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 2 | |
Caffeine | −14.9 | −15.0 | −16.5 | −16.4 | −16.3 | −16.5 | −16.0 | −16.0 | −16.4 | −16.5 |
Berberine | −18.5 | −18.8 | −22.9 | −22.3 | −23.2 | −22.7 | −17.7 | −18.1 | −20.0 | −21.6 |
Camptothecin | −18.5 | −18.6 | −22.0 | −22.0 | −22.2 | −22.6 | −19.4 | −19.3 | −22.1 | −22.4 |
Chelerythrine | −19.7 | −20.4 | −21.1 | −21.4 | −22.8 | −22.2 | −20.2 | −20.2 | −21.6 | −21.9 |
Doxorubicin | −26.7 | −26.0 | −25.3 | −25.3 | −26.1 | −26.1 | −25.7 | −25.3 | −23.7 | −23.5 |
Ellipticine | −18.1 | −17.8 | −20.8 | −20.8 | −20.8 | −20.8 | −18.8 | −18.6 | −21.3 | −21.4 |
Sanguinarine | −20.1 | −20.1 | −21.6 | −21.5 | −22.7 | −23.2 | −20.3 | −20.1 | −22.1 | −22.5 |
| ||||||||||
Ligand | 1DL8 | 367D | 452D | 465D | Avec | |||||
| ||||||||||
1 | 2 | 1 | 2 | 1 | 2 | 1 | 2 | |||
| ||||||||||
Caffeine | −16.4 | −16.5 | −16.4 | −16.7 | −16.5 | −16.7 | −16.5 | −16.7 | −16.3 | |
Berberine | −23.1 | −23.3 | −22.9 | −20.1 | −23.2 | −23.4 | −19.1 | −20.1 | −21.2 | |
Camptothecin | −22.2 | −22.6 | −22.4 | −22.8 | −22.1 | −23.3 | −21.6 | −22.9 | −21.6 | |
Chelerythrine | −22.6 | −21.6 | −22.9 | −22.4 | −23.1 | −23.1 | −21.9 | −22.6 | −21.8 | |
Doxorubicin | −25.7 | −25.3 | −25.4 | −27.3 | −26.5 | −26.7 | −23.9 | −26.4 | −25.6 | |
Ellipticine | −20.9 | −21.0 | −21.0 | −21.0 | −20.7 | −20.9 | −20.5 | −20.5 | −20.3 | |
Sanguinarine | −22.4 | −22.9 | −22.7 | −23.3 | −23.0 | −23.8 | −21.8 | −23.3 | −22.1 |
Protein Data Bank identification number.
Intercalation site number in the DNA structure.
Average intercalation docking energy for all structures.